0001209191-12-002595.txt : 20120106 0001209191-12-002595.hdr.sgml : 20120106 20120106172437 ACCESSION NUMBER: 0001209191-12-002595 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120104 FILED AS OF DATE: 20120106 DATE AS OF CHANGE: 20120106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ray Sharon Kay CENTRAL INDEX KEY: 0001422412 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09927 FILM NUMBER: 12515525 MAIL ADDRESS: STREET 1: 1211 N. WESTSHORE BLVD. STREET 2: SUITE 512 CITY: TAMPA STATE: FL ZIP: 33607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COMPREHENSIVE CARE CORP CENTRAL INDEX KEY: 0000022872 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 952594724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3405 W. DR. MARTIN LUTHER KING JR. BLVD. STREET 2: SUITE 101 CITY: TAMPA STATE: FL ZIP: 33607 BUSINESS PHONE: 813-288-4808 MAIL ADDRESS: STREET 1: 3405 W. DR. MARTIN LUTHER KING JR. BLVD. STREET 2: SUITE 101 CITY: TAMPA STATE: FL ZIP: 33607 FORMER COMPANY: FORMER CONFORMED NAME: NEURO PSYCHIATRIC & HEALTH SERVICES DATE OF NAME CHANGE: 19730501 FORMER COMPANY: FORMER CONFORMED NAME: NEURO PSYCHIATRIC & HEALTH SERVICES INC DATE OF NAME CHANGE: 19700402 FORMER COMPANY: FORMER CONFORMED NAME: JADE OIL CO DATE OF NAME CHANGE: 19700402 4 1 doc4.xml FORM 4 SUBMISSION X0304 4 2012-01-04 0 0000022872 COMPREHENSIVE CARE CORP CHCR 0001422412 Ray Sharon Kay 3405 W DR MARTIN LUTHER KING JR BLVD SUITE 101 TAMPA FL 33607 1 0 0 0 Warrant to purchase Series D Convertible Preferred Stock 25000.00 2012-01-04 4 D 0 3 25000.00 D 2009-03-31 2012-03-31 Series D Convertible Preferred Stock 3 0 D Series D Convertible Preferred Stock 2012-01-04 4 A 0 25 0.00 A 2022-01-04 Common Stock 2500000 25 D On December 29, 2011 the Board of Directors approved a restricted stock grant of the Series D Convertible Preferred Stock ("Series D Stock"), which was granted to the Reporting Person on January 4, 2012. As a condition of the grant, the Reporting Person surrendered for cancellation all warrants for the purchase of shares of Series D Stock held by the Reporting Person. The restricted shares of Series D Stock will vest on the 10th anniversary of the grant date. The restricted shares will, however, have the voting, dividend, liquidation and other rights of a share of Series D Stock effective from the date of grant. After the 10th anniversary of the grant date, each share of Series D Stock may be converted into 100,000 shares of the Issuer's Common Stock. Shares of Series D Stock have no expiration date. /s/ Scott Bates as attorney-in-fact for Sharon Kay Ray 2012-01-06